Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dyne Therapeutics Inc (DYN)

Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dyne Therapeutics Inc 1560 TRAPELO ROAD WALTHAM MA 02451 USA

www.dyne-tx.com Employees: 258 P: 781-786-8230 F: 781-786-8866

Sector:

Medical

Description:

Dyne Therapeutics Inc. is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The company's proprietary platform includes FORCE(TM). Dyne Therapeutics Inc. is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 2,919,328
Enterprise Value, $K 2,174,878
Shares Outstanding, K 165,027
Float, K 130,751
% Float 79.23%
Short Interest, K 19,153
Short Float 11.61%
Days to Cover 11.52
Short Volume Ratio 0.49
% of Insider Shareholders 20.77%
% of Institutional Shareholders 96.68%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -446,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -111,960 K
EBIT, $ -468,180 K
EBITDA, $ -467,970 K

Growth:

1-Year Return 72.00%
3-Year Return 44.29%
5-Year Return 11.89%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 15.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.76 on 11/05/25
Next Earnings Date 05/14/26
Earnings Per Share ttm -3.54
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 13.64%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 06/17/02
Dividend Payout Ratio 0.00%

DYN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.46%
Return-on-Assets % -50.94%
Profit Margin % 0.00%
Debt/Equity 0.15
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.18
Book Value/Share 6.81
Interest Coverage -71.09
60-Month Beta 1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar